Log In
Print
BCIQ
Print
Print this Print this
 

AGT-182

  Manage Alerts
Collapse Summary General Information
Company ArmaGen Technologies Inc.
DescriptionIduronate-2-sulfatase (IDS) using Trojan horse technology
Molecular Target
Mechanism of ActionEnzyme replacement therapy
Latest Stage of DevelopmentPreclinical
IndicationMucopolysaccharidosis
Partner

 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today